₨ Official source-observed price
PKR 7,557.78
14
PKR 539.84 / tablet
✓ Official DRAP price source observed · Source checked 2026-08-27
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 539.84/ tablet
Price position15% below medianvs like-for-like peer median
Peer comparators6current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sofosbuvir + Velpatasvir
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05AP
- Strength
- 400 mg + 100 mg
- Dosage form
- Tablet
- Pack
- 14
- Registration no.
- 099827
- Price record verified
- 2026-09-08
- Latest DRAP source check
- 2026-08-27 02:56
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 7,557.78 | 2026-07-27 | 2026-09-08 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
ABRIVA PLUS 400 mg + 100 mgCCL Pharmaceuticals (Pvt.) LimitedCure-C Forte 400 mg + 100 mgGlobal Pharmaceuticals (Pvt.) Ltd. · PKR 12,392.20Dowvir 400 mg + 100 mgMartin Dow Limited · PKR 19,821.26Epclusa 100 mg + 400 mgFerozsons Laboratories Limited · PKR 72,137.00Epclusa 100 mg + 400 mgFerozsons Laboratories Limited · PKR 61,317.23Hepgard-V 400 mg + 100 mgBarrett Hodgson Pakistan (Pvt.) Ltd · PKR 17,235.87OCVIR-V 400 mg + 100 mgSAMI Pharmaceuticals Pvt. Ltd. · PKR 19,947.37Sofonil Plus 400 mg + 100 mgNovaMed Pharmaceuticals(Pvt.)Ltd · PKR 8,028.63
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 099827MedInfoBase. (2026). Fosbu 400 mg + 100 mg Tablet (14), Highnoon Laboratories Ltd — registration and price record [Data set]. MedInfoBase. Retrieved September 18, 2026, from https://medinfobase.com/brand/fosbu-400-mg-100-mg-099827-14-highnoon-laboratories-ltd/ Data observed 8 September 2026. Source: DRAP PharmaPrice Index. DRAP registration 099827.
MedInfoBase. Fosbu 400 mg + 100 mg Tablet (14), Highnoon Laboratories Ltd — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 18]. Available from: https://medinfobase.com/brand/fosbu-400-mg-100-mg-099827-14-highnoon-laboratories-ltd/ Data observed 8 September 2026. Source: DRAP PharmaPrice Index. DRAP registration 099827.
MedInfoBase (2026) Fosbu 400 mg + 100 mg Tablet (14), Highnoon Laboratories Ltd — registration and price record. Available at: https://medinfobase.com/brand/fosbu-400-mg-100-mg-099827-14-highnoon-laboratories-ltd/ (Accessed: 18 September 2026).
"Fosbu 400 mg + 100 mg Tablet (14), Highnoon Laboratories Ltd — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/fosbu-400-mg-100-mg-099827-14-highnoon-laboratories-ltd/. Accessed 18 Sep 2026.
MedInfoBase. 2026. "Fosbu 400 mg + 100 mg Tablet (14), Highnoon Laboratories Ltd — registration and price record." Accessed September 18, 2026. https://medinfobase.com/brand/fosbu-400-mg-100-mg-099827-14-highnoon-laboratories-ltd/.
Price and registration data on this page were observed on 8 September 2026. Records change over time, so please cite the observation date alongside the access date.